• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BPTH

BPTH

Bio-Path Holdings, Inc.

OTCHealthcareBiotechnologyUS

USD0.03

-0.01 (-25.00%)

Rating:C

Company Profile

CEO

Vikram Paul Grover

IPO Date

2008-03-04

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.02

Prev. Close

$0.04

Day Low

$0.02

Day High

$0.04

52W Low

$0.01

52W High

$0.23

Market Cap

$0.00B

Volume

0.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

27.0%

Avg Negative

12.3%

Avg Neutral

60.7%

News Feed

BPTH Stock: Why Little-Known Bio-Path Holding Just Popped More Than 20%

InvestorPlace·8/24/2021·↑ positive

Why Bio-Path Holdings Shares Are Surging Higher Today

Benzinga·8/24/2021·↓ negative

Why Bio-Path Shares Are Moving Higher In Premarket Tuesday?

Benzinga·8/24/2021·↑ positive

Bio-Path Holdings Shares Increase Over 30% Pre-Market: Why It Happened

Pulse2·8/24/2021·↑ positive

Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients

GlobeNewsWire·8/24/2021·↑ positive

Bio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/13/2021·↓ negative

Bio-Path Holdings Reports Second Quarter 2021 Financial Results

GlobeNewsWire·8/13/2021·↓ negative

Bio-Path Holdings to Announce Second Quarter 2021 Financial Results on August 13, 2021

GlobeNewsWire·8/6/2021·↑ positive

Bio-Path Granted Key Mechanism of Action U.S. Patent for BP1003

GlobeNewsWire·6/22/2021·↑ positive

Bio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/14/2021·↓ negative